Misha Dagan

55 Commercial Road
Melbourne, VIC 3004, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Type 2 Diabetes in Heart Failure with Preserved and Mildly-Reduced Ejection Fraction: Insights from the REDUCE-LAP-HF II trial.

Type 2 Diabetes in Heart Failure with Preserved and Mildly-Reduced Ejection Fraction: Insights from the REDUCE-LAP-HF II trial.

Journal: ESC heart failure

Published: June 21, 2026

Interpreting central hemodynamics in durable biventricular circulatory support patients.

Interpreting central hemodynamics in durable biventricular circulatory support patients.

Journal: JHLT open

Published: April 30, 2026

An abbreviated exercise right heart catheterization protocol for the diagnosis of heart failure with preserved ejection fraction.

An abbreviated exercise right heart catheterization protocol for the diagnosis of heart failure with preserved ejection fraction.

Journal: Journal of cardiac failure

Published: April 06, 2026

Mechanisms of GLP-1 Receptor Agonists in HFpEF: Exploring Weight-Dependent and Independent Drivers of Therapeutic Benefit.

Mechanisms of GLP-1 Receptor Agonists in HFpEF: Exploring Weight-Dependent and Independent Drivers of Therapeutic Benefit.

Journal: Circulation. Heart failure

Published: March 25, 2026

Pulmonary Hypertension Under the Microscope: What Histopathology Means for Diagnosis and Treatment.

Pulmonary Hypertension Under the Microscope: What Histopathology Means for Diagnosis and Treatment.

Journal: Chest

Published: March 10, 2026

Incidence and Outcomes of Emergency Medical Service Treated Pulmonary Embolism in Victoria, Australia; A Population-Based Cohort Study.

Incidence and Outcomes of Emergency Medical Service Treated Pulmonary Embolism in Victoria, Australia; A Population-Based Cohort Study.

Journal: Annals of epidemiology

Published: February 26, 2026

Venous vascular pharmacology: how does it contribute to heart failure with preserved ejection fraction?

Venous vascular pharmacology: how does it contribute to heart failure with preserved ejection fraction?

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: February 08, 2026

Patient-Specific Haemodynamic Modeling to Estimate the Extent of Microvascular Disease and Response to Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension.

Patient-Specific Haemodynamic Modeling to Estimate the Extent of Microvascular Disease and Response to Pulmonary Endarterectomy in Chronic Thromboembolic Pulmonary Hypertension.

Journal: Pulmonary circulation

Published: July 11, 2025

Insights into pulmonary remodelling in heart failure with preserved ejection fraction through transpulmonary biomarker gradients.

Insights into pulmonary remodelling in heart failure with preserved ejection fraction through transpulmonary biomarker gradients.

Journal: Cardiovascular research

Published: March 07, 2025

Small vessels, big problem: a dive into the pulmonary microcirculation in pulmonary hypertension and methods for evaluation.

Small vessels, big problem: a dive into the pulmonary microcirculation in pulmonary hypertension and methods for evaluation.

Journal: EBioMedicine

Published: March 02, 2025

Comparison of Continuous Milrinone Versus Dobutamine on Pulmonary Pressures in Patients With Advanced Heart Failure.

Comparison of Continuous Milrinone Versus Dobutamine on Pulmonary Pressures in Patients With Advanced Heart Failure.

Journal: Journal of the American Heart Association

Published: January 10, 2025

Cardiac medication non-adherence: the elephant in the room.

Cardiac medication non-adherence: the elephant in the room.

Journal: Internal medicine journal

Published: November 24, 2024

Showing 1-12 of 40

Last Updated: 09/26/2026